Changeflow GovPing Healthcare & Life Sciences Verily Health Inc. Patent US12605063B2 — Visual...
Routine Notice Added Final

Verily Health Inc. Patent US12605063B2 — Visual Acuity Measurement in VR Headset

Favicon for changeflow.com USPTO Patent Grants - Diagnosis & Surgery (A61B)
Published
Detected
Email

Summary

The USPTO granted Patent US12605063B2 to Verily Health Inc. on April 21, 2026. The patent covers a dual-display virtual reality headset with dichroic filter optics configured for automated visual acuity testing, using a smaller secondary display synchronized with pixel-control circuitry to present test patterns. The application was filed March 30, 2023, with 20 claims allowed.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The USPTO issued Patent US12605063B2 to Verily Health Inc. covering a VR headset system with two displays of differing size and resolution, a dichroic filter routing visible light from each display toward the eye, and control circuitry that darkens the primary display while activating the secondary display to present visual acuity test patterns. CPC classifications span A61B (diagnosis/surgery), G02B (optics), and G06F (input technology).

Manufacturers developing VR-based vision testing applications or medical-optics devices should review the claim scope to assess potential freedom-to-operate considerations. The patent's dual-display architecture with synchronized test-pattern activation may overlap with existing or planned product roadmaps in digital health and diagnostic eyewear.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Visual acuity measurement in VR headset

Grant US12605063B2 Kind: B2 Apr 21, 2026

Assignee

Verily Health Inc.

Inventors

Supriyo Sinha, Nick Leindecker, Jeremy Chan, Dimitri Azar

Abstract

A headset includes a first display, a second display that is smaller than the first display and has lower resolution than the first display, and a dichroic filter positioned to pass visible light from the first display toward the eye and reflect visible light from the second display toward the eye. Pixel data control circuitry is coupled to darken the first display while simultaneously activating the second display to display a pattern for testing visual acuity, responsive to a first visual acuity test selection. Other aspects are also described and claimed.

CPC Classifications

A61B 3/028 A61B 3/032 A61B 3/0041 G02B 27/017 G06F 3/013

Filing Date

2023-03-30

Application No.

18193193

Claims

20

View original document →

Get daily alerts for USPTO Patent Grants - Diagnosis & Surgery (A61B)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 21st, 2026
Instrument
Notice
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12605063B2

Who this affects

Applies to
Medical device makers Technology companies
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent granting IP licensing
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Medical Devices

Get alerts for this source

We'll email you when USPTO Patent Grants - Diagnosis & Surgery (A61B) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!